Equity Overview
Price & Market Data
Price: $0.47
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $7,071,798
Daily Volume: 0
Performance Metrics
1 Week: -17.50%
1 Month: -21.64%
3 Months: -46.77%
6 Months: -73.43%
1 Year: 74.17%
YTD: -32.73%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company has a partnership with EmeritusDX for the development of non-invasive blood testing technologies. AccuStem Sciences, Inc. was founded in 2013 and is headquartered in New York, New York.